These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27388768)

  • 1. New Found Hope for Antibiotic Discovery: Lipid II Inhibitors.
    Ng V; Chan WC
    Chemistry; 2016 Aug; 22(36):12606-16. PubMed ID: 27388768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.
    Chiorean S; Antwi I; Carney DW; Kotsogianni I; Giltrap AM; Alexander FM; Cochrane SA; Payne RJ; Martin NI; Henninot A; Vederas JC
    Chembiochem; 2020 Mar; 21(6):789-792. PubMed ID: 31552694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin.
    Zong Y; Sun X; Gao H; Meyer KJ; Lewis K; Rao Y
    J Med Chem; 2018 Apr; 61(8):3409-3421. PubMed ID: 29629769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
    Oppedijk SF; Martin NI; Breukink E
    Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting bactoprenol-coupled cell envelope precursors.
    Ulm H; Schneider T
    Appl Microbiol Biotechnol; 2016 Sep; 100(18):7815-25. PubMed ID: 27495122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid II as a target for antibiotics.
    Breukink E; de Kruijff B
    Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of teixobactins in cellular membranes.
    Shukla R; Medeiros-Silva J; Parmar A; Vermeulen BJA; Das S; Paioni AL; Jekhmane S; Lorent J; Bonvin AMJJ; Baldus M; Lelli M; Veldhuizen EJA; Breukink E; Singh I; Weingarth M
    Nat Commun; 2020 Jun; 11(1):2848. PubMed ID: 32503964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
    Grein F; Schneider T; Sahl HG
    J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teixobactins: a new class of 21st century antibiotics to combat multidrug-resistant bacterial pathogens.
    Iyer A; Madder A; Singh I
    Future Microbiol; 2019 Apr; 14():457-460. PubMed ID: 31033354
    [No Abstract]   [Full Text] [Related]  

  • 10. Expanding role of lipid II as a target for lantibiotics.
    Martin NI; Breukink E
    Future Microbiol; 2007 Oct; 2(5):513-25. PubMed ID: 17927474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding Site and Potency Prediction of Teixobactin and other Lipid II Ligands by Statistical Base Scoring of Conformational Space Maps.
    Lungu CN; Diudea MV
    Curr Comput Aided Drug Des; 2018; 14(1):29-34. PubMed ID: 28969532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Synthesis of Laspartomycin C and Characterization of Its Antibacterial Mechanism of Action.
    Kleijn LH; Oppedijk SF; 't Hart P; van Harten RM; Martin-Visscher LA; Kemmink J; Breukink E; Martin NI
    J Med Chem; 2016 Apr; 59(7):3569-74. PubMed ID: 26967152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery.
    Fiers WD; Craighead M; Singh I
    ACS Infect Dis; 2017 Oct; 3(10):688-690. PubMed ID: 28770988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple attack on bacteria by the new antibiotic teixobactin.
    von Nussbaum F; Süssmuth RD
    Angew Chem Int Ed Engl; 2015 Jun; 54(23):6684-6. PubMed ID: 25968231
    [No Abstract]   [Full Text] [Related]  

  • 15. The Necessity of d-Thr in the New Antibiotic Teixobactin: A Molecular Dynamics Study.
    Liu Y; Li W; Chan-Park MB; Mu Y
    J Chem Inf Model; 2019 Apr; 59(4):1575-1583. PubMed ID: 30855952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway.
    Schneider T; Sahl HG
    Int J Med Microbiol; 2010 Feb; 300(2-3):161-9. PubMed ID: 20005776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial mechanism of lantibiotics.
    Islam MR; Nagao J; Zendo T; Sonomoto K
    Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the peptide moiety of Lipid II on bacterial transglycosylase.
    Shih HW; Chang YF; Li WJ; Meng FC; Huang CY; Ma C; Cheng TJ; Wong CH; Cheng WC
    Angew Chem Int Ed Engl; 2012 Oct; 51(40):10123-6. PubMed ID: 22952114
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural Insights into the Mode of Action of the Peptide Antibiotic Copsin.
    Franzoi M; van Heuvel Y; Thomann S; Schürch N; Kallio PT; Venier P; Essig A
    Biochemistry; 2017 Sep; 56(37):4992-5001. PubMed ID: 28825809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies?
    van Harten RM; Willems RJL; Martin NI; Hendrickx APA
    Trends Microbiol; 2017 Jun; 25(6):467-479. PubMed ID: 28209400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.